Vascular effects of arginine-vasopressin, angiotensin and noradrenaline in adrenal insufficiency.
D000309:Adrenal Insufficiency / Q000503:physiopathology*; D000315:Adrenalectomy; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000809:Angiotensins / Q000502:physiology*; D000818:Animals; D001127:Arginine Vasopressin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects*; D009638:Norepinephrine / Q000502:physiology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D051381:Rats
D000809:Angiotensins; D010643:Phenoxybenzamine; D000804:Angiotensin II; D001127:Arginine Vasopressin; C025043:vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine-; D009638:Norepinephrine